Our flexible approach supports the modelling of new and established pathogens and the impact of interventions and behavioural modifications. We have an in-house stochastic SEIR Model that can be used to produce deterministic scenarios, stochastic event sets and Exceedance Probability curves for any combination of pathogen type, characteristics and intervention. We have calibrated our novel coronavirus model to both the United States and the United Kingdom, and are able to produce a full stochastic distribution for future novel coronavirus pandemics. We also have an in-house approach to estimating both direct and indirect excess mortality for insured lives, allowing for differences in demographic, health and socioeconomic status.